Cargando…

Quantification of NADH:ubiquinone oxidoreductase (complex I) content in biological samples

Impairments in mitochondrial energy metabolism have been implicated in human genetic diseases associated with mitochondrial and nuclear DNA mutations, neurodegenerative and cardiovascular disorders, diabetes, and aging. Alteration in mitochondrial complex I structure and activity has been shown to p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ansari, Fariha, Yoval-Sánchez, Belem, Niatsetskaya, Zoya, Sosunov, Sergey, Stepanova, Anna, Garcia, Christian, Owusu-Ansah, Edward, Ten, Vadim, Wittig, Ilka, Galkin, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Methods and Resources
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503622/ https://www.ncbi.nlm.nih.gov/pubmed/34543622 http://dx.doi.org/10.1016/j.jbc.2021.101204

Ejemplares similares

The Subunit Composition of Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I) From Pichia pastoris
por: Bridges, Hannah R., et al.
Publicado: (2010)

Reduction of Hydrophilic Ubiquinones by the Flavin in Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I) and Production of Reactive Oxygen Species
por: King, Martin S., et al.
Publicado: (2009)

Effects of the deletion of the Escherichia coli frataxin homologue CyaY on the respiratory NADH:ubiquinone oxidoreductase
por: Pohl, Thomas, et al.
Publicado: (2007)

Redox-dependent loss of flavin by mitochondria complex I is different in brain and heart
por: Yoval-Sánchez, Belem, et al.
Publicado: (2022)

The MoxR ATPase RavA and Its Cofactor ViaA Interact with the NADH:Ubiquinone Oxidoreductase I in Escherichia coli
por: Wong, Keith S., et al.
Publicado: (2014)

Clinical Relevance and Tumor Growth Suppression of Mitochondrial ROS Regulators along NADH:Ubiquinone Oxidoreductase Subunit B3 in Thyroid Cancer
por: Zhu, Jiao, et al.
Publicado: (2022)

Origin and Evolution of the Sodium -Pumping NADH: Ubiquinone Oxidoreductase
por: Reyes-Prieto, Adrian, et al.
Publicado: (2014)

A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum
por: Ward, Steve A, et al.
Publicado: (2010)

Cryo-EM structures of Na(+)-pumping NADH-ubiquinone oxidoreductase from Vibrio cholerae
por: Kishikawa, Jun-ichi, et al.
Publicado: (2022)

Attenuation of oxidative damage by targeting mitochondrial complex I in neonatal hypoxic-ischemic brain injury
por: Kim, Minso, et al.
Publicado: (2018)

Developmental window of vulnerability to white matter injury driven by sublethal intermittent hypoxemia
por: Sosunov, Sergey A., et al.
Publicado: (2022)

Mitochondrial Dysfunction and Permeability Transition in Neonatal Brain and Lung Injuries
por: S. Ten, Vadim, et al.
Publicado: (2021)

Krebs cycle metabolites and preferential succinate oxidation following neonatal hypoxic-ischemic brain injury in mice
por: Sahni, Prateek V., et al.
Publicado: (2017)

In vitro characterization of mitochondrial function and structure in rat and human cells with a deficiency of the NADH: ubiquinone oxidoreductase Ndufc2 subunit
por: Raffa, Salvatore, et al.
Publicado: (2017)

Mitochondrial calcium buffering depends upon temperature and is associated with hypothermic neuroprotection against hypoxia-ischemia injury
por: Sosunov, Sergey, et al.
Publicado: (2022)

Isoflurane Anesthesia Initiated at the Onset of Reperfusion Attenuates Oxidative and Hypoxic-Ischemic Brain Injury
por: Sosunov, Sergey A., et al.
Publicado: (2015)

The mechanism of catalysis by type-II NADH:quinone oxidoreductases
por: Blaza, James N., et al.
Publicado: (2017)

Nelfinavir Inhibits Intra-Mitochondrial Calcium Influx and Protects Brain against Hypoxic-Ischemic Injury in Neonatal Mice
por: Utkina-Sosunova, Irina V., et al.
Publicado: (2013)

DHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice
por: Mayurasakorn, Korapat, et al.
Publicado: (2016)

A novel cytosolic NADH:quinone oxidoreductase from Methanothermobacter marburgensis
por: Ullmann, Eva, et al.
Publicado: (2014)

Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from S. aureus
por: Sena, Filipa V., et al.
Publicado: (2018)

Occurrence and Function of the Na(+)-Translocating NADH:Quinone Oxidoreductase in Prevotella spp.
por: Deusch, Simon, et al.
Publicado: (2019)

Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma
por: Ragab, Eman M., et al.
Publicado: (2022)

Ubiquinone binding site of yeast NADH dehydrogenase revealed by structures binding novel competitive- and mixed-type inhibitors
por: Yamashita, Tetsuo, et al.
Publicado: (2018)

Mutation of a distal gating residue modulates NADH binding in NADH:Quinone oxidoreductase from Pseudomonas aeruginosa PAO1
por: Moni, Bilkis Mehrin, et al.
Publicado: (2023)

Role of NADH: quinone oxidoreductase-1 in the tight junctions of colonic epithelial cells
por: Nam, Seung Taek, et al.
Publicado: (2014)

The multidomain flavodiiron protein from Clostridium difficile 630 is an NADH:oxygen oxidoreductase
por: Folgosa, Filipe, et al.
Publicado: (2018)

Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase
por: Biagini, Giancarlo A, et al.
Publicado: (2010)

Structural and Functional insights into the catalytic mechanism of the Type II NADH:quinone oxidoreductase family
por: Marreiros, Bruno C., et al.
Publicado: (2017)

The Profound Influence of Lipid Composition on the Catalysis of the Drug Target NADH Type II Oxidoreductase
por: Godoy-Hernandez, Albert, et al.
Publicado: (2021)

Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA
por: Ratti, Alessandro, et al.
Publicado: (2023)

Conformational coupling of redox-driven Na(+)-translocation in Vibrio cholerae NADH:quinone oxidoreductase
por: Hau, Jann-Louis, et al.
Publicado: (2023)

A Self‐Assembled Respiratory Chain that Catalyzes NADH Oxidation by Ubiquinone‐10 Cycling between Complex I and the Alternative Oxidase
por: Jones, Andrew J. Y., et al.
Publicado: (2015)

Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy
por: Liu, Hsin-Yu, et al.
Publicado: (2011)

Impairment of electron transport chain and induction of apoptosis by chrysin nanoparticles targeting succinate-ubiquinone oxidoreductase in pancreatic and lung cancer cells
por: Ragab, Eman M., et al.
Publicado: (2023)

Higher NADH Dehydrogenase [Ubiquinone] Iron–Sulfur Protein 8 (NDUFS8) Serum Levels Correlate with Better Insulin Sensitivity in Type 1 Diabetes
por: Flotyńska, Justyna, et al.
Publicado: (2022)

Phylogenomic Analysis and Predicted Physiological Role of the Proton-Translocating NADH:Quinone Oxidoreductase (Complex I) Across Bacteria
por: Spero, Melanie A., et al.
Publicado: (2015)

A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity
por: Deris, Zakuan Z., et al.
Publicado: (2013)

Roles of the Sodium-Translocating NADH:Quinone Oxidoreductase (Na(+)-NQR) on Vibrio cholerae Metabolism, Motility and Osmotic Stress Resistance
por: Minato, Yusuke, et al.
Publicado: (2014)

Increased availability of NADH in metabolically engineered baker’s yeast improves transaminase-oxidoreductase coupled asymmetric whole-cell bioconversion
por: Knudsen, Jan Dines, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hv3s66htu9sge2ffgkjaosaepl